TI
BBNX

Trexquant Investment’s Beta Bionics BBNX Stock Holding History

Trexquant Investment’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.42M Buy
241,601
+125,840
+109% +$1.86M 0.02% 922
2025
Q4 		$3.53M Buy
+115,761
New +$3.09M 0.03% 754

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Trexquant Investment's BBNX Position: Q1 2026 in Review

Trexquant Investment increased its Beta Bionics (BBNX) stake by 109% in Q1 2026, buying an estimated $1.86M and bringing the position to 241,601 shares worth $2.42M. The position accounts for 0.02% of the portfolio, ranked #922.

Trexquant Investment first reported a position in BBNX in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.53M in Q4 2025. 130 funds tracked by Wall St. Rank hold BBNX as of Q1 2026.

  • Trexquant Investment held 241,601 shares of Beta Bionics worth $2.42M as of Q1 2026.
  • Trexquant Investment bought 125,840 Beta Bionics shares in Q1 2026, an estimated $1.86M.
  • Beta Bionics made up 0.02% of Trexquant Investment's portfolio in Q1 2026, its #922 holding.
  • Trexquant Investment first reported a position in Beta Bionics in Q4 2025 and has held it in 2 quarters since.
  • Trexquant Investment's Beta Bionics position peaked at $3.53M in Q4 2025.
  • 130 funds tracked by Wall St. Rank held Beta Bionics as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.